The role of PKCα in vascular pathology: Perspectives from Dr. Samantha Borland’s research
Janeway · 12.09.2025 · 1 (7)
DOI: 10.57898/bioscientist.305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Janeway, erschienen am 12.09.2025. Verfasst von Aliya Sajid und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vascular calcification is a significant health concern, particularly for individualswith chronic kidney disease, yet no approved treatments currently exist.Understanding the molecular mechanisms underlying this process is crucial fordeveloping effective therapeutic strategies. This interview explores theresearch journey of Dr. Samantha Borland, tracing her academic background, keydiscoveries, and ongoing investigations into the role of Protein Kinase Cα(PKCα) in vascular calcification. Dr. Borland discusses the potential oftargeted therapies, including drug repurposing and natural compounds, andhighlights the challenges associated with translating research findings intoclinical applications. The discussion also emphasises the importance ofinterdisciplinary collaboration and future directions in combating vascularcalcification.
Schlagwörter
Zitieren
APA
Sajid, A., Fathulla, S., & Borland, D. S. (2025). The role of PKCα in vascular pathology: Perspectives from Dr. Samantha Borland’s research. Janeway, 1(7). https://doi.org/10.57898/bioscientist.305
Vancouver
Sajid A, Fathulla S, Borland DS. The role of PKCα in vascular pathology: Perspectives from Dr. Samantha Borland’s research. Janeway. 2025;1(7). doi:10.57898/bioscientist.305
BibTeX
@article{Sajid2025,
author = {Sajid, Aliya and Fathulla, Sanaria and Borland, Dr Samantha},
title = {The role of PKCα in vascular pathology: Perspectives from Dr. Samantha Borland’s research},
journal = {Janeway},
year = {2025},
volume = {1},
number = {7},
doi = {10.57898/bioscientist.305}
}
EUVIMED